WallStreetZenWallStreetZen

NASDAQ: CLGN
Collplant Biotechnologies Ltd Stock

Open Broker Account
$6.30-0.58 (-8.43%)
Updated Sep 27, 2022
CLGN Price
$6.30
Fair Value Price
N/A
Market Cap
$69.84M
52 Week Low
$6.18
52 Week High
$23.00
P/E
-4.41x
P/B
1.77x
P/S
152.39x
PEG
N/A
Dividend Yield
N/A
Revenue
$582.00k
Earnings
-$14.99M
Gross Margin
-31.3%
Operating Margin
-2,610.48%
Profit Margin
-2,576.3%
Debt to Equity
0.12
Operating Cash Flow
-$12M
Beta
0.64
Next Earnings
Nov 16, 2022
Ex-Dividend
N/A
Next Dividend
N/A

CLGN Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CLGN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CLGN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CLGN is good value based on its book value relative to its share price (1.77x), compared to the US Biotechnology industry average (4.3x)
P/B vs Industry Valuation
CLGN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CLGN due diligence checks available for Premium users.

Be the first to know about important CLGN news, forecast changes, insider trades & much more!

CLGN News

Valuation

CLGN fair value

Fair Value of CLGN stock based on Discounted Cash Flow (DCF)
Price
$6.30
Fair Value
$9.95
Undervalued by
36.68%
CLGN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CLGN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.41x
Industry
15.18x
Market
28.09x

CLGN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.77x
Industry
4.3x
CLGN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CLGN's financial health

Profit margin

Revenue
$66.0k
Net Income
-$4.3M
Profit Margin
-6,492.4%
CLGN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CLGN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$44.4M
Liabilities
$4.9M
Debt to equity
0.12
CLGN's short-term assets ($38.27M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLGN's short-term assets ($38.27M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLGN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.0M
Investing
-$337.0k
Financing
$0.0
CLGN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CLGN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CLGN$69.84M-8.43%-4.41x1.77x
PASG$69.71M+2.40%-0.38x0.28x
CNTB$69.48M0.00%-0.69x0.34x
IBIO$68.94M-1.25%-2.11x0.87x
SPRO$70.84M-3.35%-0.58x1.97x

Collplant Biotechnologies Stock FAQ

What is Collplant Biotechnologies's quote symbol?

NASDAQ: CLGN) Collplant Biotechnologies trades on the NASDAQ under the ticker symbol CLGN. Collplant Biotechnologies stock quotes can also be displayed as NASDAQ: CLGN.

If you're new to stock investing, here's how to buy Collplant Biotechnologies stock.

What is the 52 week high and low for Collplant Biotechnologies (NASDAQ: CLGN)?

(NASDAQ: CLGN) Collplant Biotechnologies's 52-week high was $23.00, and its 52-week low was $6.18. It is currently -72.61% from its 52-week high and 1.94% from its 52-week low.

How much is Collplant Biotechnologies stock worth today?

(NASDAQ: CLGN) Collplant Biotechnologies currently has 11,086,481 outstanding shares. With Collplant Biotechnologies stock trading at $6.30 per share, the total value of Collplant Biotechnologies stock (market capitalization) is $69.84M.

Collplant Biotechnologies stock was originally listed at a price of $8.95 in Jan 31, 2018. If you had invested in Collplant Biotechnologies stock at $8.95, your return over the last 4 years would have been -29.61%, for an annualized return of -8.4% (not including any dividends or dividend reinvestments).

How much is Collplant Biotechnologies's stock price per share?

(NASDAQ: CLGN) Collplant Biotechnologies stock price per share is $6.30 today (as of Sep 27, 2022).

What is Collplant Biotechnologies's Market Cap?

(NASDAQ: CLGN) Collplant Biotechnologies's market cap is $69.84M, as of Sep 28, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Collplant Biotechnologies's market cap is calculated by multiplying CLGN's current stock price of $6.30 by CLGN's total outstanding shares of 11,086,481.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.